Reuters logo
BRIEF-Aptevo Therapeutics Inc's reports Q2 loss per share $0.53
August 10, 2017 / 1:35 PM / in 2 months

BRIEF-Aptevo Therapeutics Inc's reports Q2 loss per share $0.53

Aug 10 (Reuters) - Aptevo Therapeutics Inc:

* Aptevo Therapeutics reports second quarter 2017 financial results

* Q2 loss per share $0.53

* Aptevo Therapeutics Inc - total product sales revenue was $10.8 million for three months ended June 30, 2017, compared to $10.2 million for same period in 2016 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below